The Oncology Institute falls on CEO transition
- The Oncology Institute has announced Monday that Dr. Daniel Virnich, president will replace Brad Hively as CEO.
- Brad Hively will step down from the CEO position, effective June 30, 2023 and will later transition to the role of Vice Chairman of the Board of Directors.
- Dr. Daniel Virnich has been with The Oncology Institute since 2020, initially as Chief Operating Officer before being promoted to President.
- TOI -9.2% premarket to $0.5629
- Source: Press Release